Sacral Nerve Stimulation Market Size, Share, Regional Growth, 2026-2034
- jhon smith
- 3 days ago
- 3 min read
Market Overview
According to fortune business insights, The global sacral nerve stimulation market size was valued at USD 2.03 billion in 2025. The market is projected to grow from USD 2.29 billion in 2026 to USD 5.94 billion by 2034, exhibiting a CAGR of 12.66% during the forecast period. North America dominated the sacral nerve stimulation market with a dominant share in 2024.
The analysis shows that top companies are investing more in sacral nerve stimulation (SNS) devices due to the increasing cases of urinary incontinence. For example, in January 2023, Axonics, Inc. received U.S. FDA approval for its fourth-generation Axonics R20 neurostimulator. This trend, combined with growing awareness about bladder disorders, indicates a strong demand for SNS devices worldwide.
Major Players Profiled in the Market Report:
Medtronic (Ireland)
Hangzhou Chengnuo Medical Technology Ltd. (China)
Boston Scientific Corporation (U.S.)
Axonics, Inc. (U.S.)
Neuspera Medical (U.S.)
Laborie (U.S.)
Segments
Increasing Regulatory Approvals to Propel Devices Segment GrowthBased on product, the market is divided into devices and accessories. The devices segment is anticipated to grow at the highest CAGR during the forecast period owing to the increasing focus of market players on receiving regulatory approvals and launching novel sacral nerve stimulation devices globally.
High Prevalence to Drive Urinary & Fecal Incontinence Segment ExpansionBy application, the market is categorized into urinary & fecal incontinence, urinary retention, constipation, and others. The urinary & fecal incontinence segment is anticipated to dominate the market due to the high global burden of these conditions.
Advanced Infrastructure to Help Hospitals & ASCs Segment Dominate the MarketBased on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others. The hospitals & ASCs segment is projected to hold the largest market share owing to their access to state-of-the-art technology and skilled professionals capable of performing complex SNS implantation procedures.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Report Coverage
The report offers:
Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
Comprehensive insights into regional developments.
List of major industry players.
Key strategies adopted by the market players.
The latest industry developments include product launches, partnerships, mergers, and acquisitions.
Drivers & Restraints
Growing Aging Population to Propel Market GrowthThe rapid growth in the aging population worldwide is a significant market driver. As the global population ages, there is a corresponding increase in the prevalence of conditions such as urinary and fecal incontinence. Since these conditions are effectively treated with sacral nerve stimulation, the demand for SNS devices is expected to rise, boosting market growth.
However, the high cost of sacral nerve stimulation devices, which can range from USD 7,964 to USD 9,291, may hamper market growth, especially in low-income countries where cheaper alternatives like medications are more accessible.
Regional Insights
Regulatory Approvals and Strong Infrastructure Propel Market Growth in North AmericaNorth America holds the dominant sacral nerve stimulation market share and is projected to experience significant growth. The region’s growth is attributed to market players' increasing focus on receiving regulatory approvals, an established healthcare infrastructure, higher healthcare spending, and a high burden of bladder disorders.
The market in Europe is anticipated to grow considerably during the forecast period. The growth is attributed to the growing aging population in the region, which is more susceptible to conditions effectively treated by sacral nerve stimulation.
Competitive Landscape
Growing Adoption of Mergers and Acquisitions to Propel Market GrowthThe market features prominent players like Medtronic, Axonics, Inc., and Boston Scientific Corporation. These leading companies are accelerating growth through strategic initiatives such as obtaining regulatory approvals for new products, expanding product offerings through strategic alliances, and engaging in mergers and acquisitions to strengthen their market position and commercialization capabilities.
Key Industry Development
January 2024: Boston Scientific Corporation announced it had entered into a definitive agreement to acquire Axonics, Inc. for an equity value of approximately USD 3.70 billion.
June 2023: Hangzhou Chengnuo Medical Technology Ltd. announced its novel implantable sacral nerve stimulator products were approved for marketing in China by the National Medical Products Administration (NMPA).
Comments